The Societal Value of Broader Access to Antiobesity Medications

OBJECTIVE: Obesity and its complications place an enormous burden on society. Yet antiobesity medications (AOM) are prescribed to only 2% of the eligible population, even though few individuals can sustain weight loss using other strategies alone. This study estimated the societal value of greater a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kabiri, Mina, Sexton Ward, Alison, Ramasamy, Abhilasha, van Eijndhoven, Emma, Ganguly, Rahul, Smolarz, B. Gabriel, Zvenyach, Tracy, Goldman, Dana P., Baumgardner, James R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003734/
https://www.ncbi.nlm.nih.gov/pubmed/31869002
http://dx.doi.org/10.1002/oby.22696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003734/
https://www.ncbi.nlm.nih.gov/pubmed/31869002
http://dx.doi.org/10.1002/oby.22696

Ejemplares similares